{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T15:33:55Z","timestamp":1781969635164,"version":"3.54.5"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s12149-026-02183-3","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:21:10Z","timestamp":1772623270000},"page":"776-785","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of environmental radioactive contamination in radiation therapy rooms: comparison between therapy after Lu-177 DOTATATE and I-131"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4283-2473","authenticated-orcid":false,"given":"Reiko","family":"Ideguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliya","family":"Toilybayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Toya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumi","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"2183_CR1","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1016\/S1470-2045(19)30821-6","volume":"21","author":"K Herrmann","year":"2020","unstructured":"Herrmann K, Schwaiger M, Lewis JS, Solomon SB, McNeil BJ, Baumann M, et al. Radiotheranostics: a roadmap for future development. Lancet Oncol. 2020;21:e146-156.","journal-title":"Lancet Oncol"},{"key":"2183_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJMoa1607427","volume":"376","author":"J Strosberg","year":"2017","unstructured":"Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, et al. Phase 3 trial of 177Lu-Dotatate for midgut neuroendocrine tumors. N Engl J Med. 2017;376:125\u201335.","journal-title":"N Engl J Med"},{"key":"2183_CR3","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2214\/AJR.18.19953","volume":"211","author":"ES Mittra","year":"2018","unstructured":"Mittra ES. Neuroendocrine tumor therapy: 177Lu- DOTATATE. AJR Am J Roentgenol. 2018;211:278\u201385.","journal-title":"AJR Am J Roentgenol"},{"key":"2183_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s13139-018-0563-4","volume":"53","author":"S Kinuya","year":"2019","unstructured":"Kinuya S. Activities for the development of targeted radionuclide therapy in Japan. Nucl Med Mol Imaging. 2019;53:35\u20137.","journal-title":"Nucl Med Mol Imaging"},{"key":"2183_CR5","unstructured":"Abe K, Ito K, Ito M, Uchiyama M, Okamoto T, Kinuya S, et al. Report on the Operation Status of RI Treatment Rooms for Radioactive Iodine Therapy in Thyroid Cancer (Report No.6). Kakuigaku 2022;59:57-67. [Japanese]"},{"key":"2183_CR6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/HP.0000000000001063","volume":"117","author":"C Karo","year":"2019","unstructured":"Karo C, Ideguchi R, Nishi K, Fukuda N, Miura M, Matuda N, et al. Radiation monitoring of an isolation room for 131I therapy after the patients were released. Health Phys. 2019;117:419\u201325.","journal-title":"Health Phys"},{"key":"2183_CR7","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/HP.0000000000001122","volume":"117","author":"KL Nelson","year":"2019","unstructured":"Nelson KL, Sheetz MA. Radiation safety observations associated with 177Lu dotatate patients. Health Phys. 2019;117:680\u20137.","journal-title":"Health Phys"},{"key":"2183_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s12149-014-0843-8","volume":"28","author":"PJ Calais","year":"2014","unstructured":"Calais PJ, Turner JH. Radiation safety of outpatient 177Lu-Octreotate radiopeptide therapy for neuroendocrine tumors. Ann Nucl Med. 2014;28:531\u20139.","journal-title":"Ann Nucl Med"},{"key":"2183_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-019-0243-1","volume":"6","author":"D Levart","year":"2019","unstructured":"Levart D, Kalogianni E, Corcoran B, Mulholland N, Vivian G. Radiation precautions for inpatient and outpatient 177Lu-DOTATATE peptide receptor radionuclide therapy of neuroendocrine tumours. EJNMMI Phys. 2019;6:7.","journal-title":"EJNMMI Phys"},{"key":"2183_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12149-018-1230-7","volume":"32","author":"M Hosono","year":"2018","unstructured":"Hosono M, Ikebuchi H, Nakamura Y, Nakamura N, Yamada T, Yanagida S, et al. Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.). Ann Nucl Med. 2018;32:217\u201335.","journal-title":"Ann Nucl Med"},{"key":"2183_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12149-011-0553-4","volume":"26","author":"T Higashi","year":"2012","unstructured":"Higashi T, Kudo T, Kinuya S. Radioactive iodine (131I) therapy for differentiated thyroid cancer in Japan: current issues with historical review and future perspective. Ann Nucl Med. 2012;26:99\u2013112.","journal-title":"Ann Nucl Med"},{"key":"2183_CR12","first-page":"27","volume":"53","author":"T Higashi","year":"2016","unstructured":"Higashi T, Ikebuchi S, Uchiyama M, Oriuchi N, Kinuya S, Hosono M. Radioisotope therapy of Japan: future perspective and recommendations. Kaku Igaku. 2016;53:27\u201343.","journal-title":"Kaku Igaku"},{"key":"2183_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s12149-024-01905-9","volume":"38","author":"A Okizaki","year":"2024","unstructured":"Okizaki A, Nishiyama Y, Inui Y, Otsuka H, Takanami K, Nakajo M, et al. Nuclear medicine practice in Japan: a report of the ninth nationwide survey in 2022. Ann Nucl Med. 2024;38:315\u201327.","journal-title":"Ann Nucl Med"},{"key":"2183_CR14","first-page":"813","volume":"49","author":"S Takano","year":"2022","unstructured":"Takano S, Kobayashi N, Ichikawa Y, Hata M. Indications and practice of a new radionuclide therapy, 177Lu-DOTATATE in Japan. Gan To Kagaku Ryoho. 2022;49:813\u201320.","journal-title":"Gan To Kagaku Ryoho"},{"key":"2183_CR15","first-page":"2110","volume":"33","author":"E Ibis","year":"1992","unstructured":"Ibis E, Wilson CR, Collier BD, Akansel G, Isitman AT, Yoss RG. Iodine-131 contamination from thyroid cancer patients. J Nucl Med. 1992;33:2110\u20135.","journal-title":"J Nucl Med"},{"key":"2183_CR16","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.2967\/jnumed.111.100123","volume":"53","author":"YK Dewaraja","year":"2012","unstructured":"Dewaraja YK, Frey EC, Sgouros G, Brill AB, Roberson P, Zanzonic PB, et al. MIRD pamphlet no. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy. J Nucl Med. 2012;53:1310\u201325.","journal-title":"J Nucl Med"},{"key":"2183_CR17","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2967\/jnumed.118.230607","volume":"60","author":"TA Hope","year":"2019","unstructured":"Hope TA, Abbott A, Colucci K, Bushnell DL, Gardner L, Graham WS, et al. NANETS\/SNMMI procedure standard for somatostatin receptor\u2013based peptide receptor radionuclide therapy with 177Lu-DOTATATE. J Nucl Med. 2019;60:937\u201343.","journal-title":"J Nucl Med"},{"key":"2183_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.14550","volume":"26","author":"SC George","year":"2025","unstructured":"George SC, Aguirre S, Maughan NM, Tolakanahalli R, Samuel EJJ, Gallo SL, et al. Enhancing safety: multi-institutional FMEA and FTA on 177Lu-based radio-pharmaceutical therapy. J Appl Clin Med Phys. 2025;26:e14550.","journal-title":"J Appl Clin Med Phys"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02183-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-026-02183-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02183-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T09:10:23Z","timestamp":1781946623000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-026-02183-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2183"],"URL":"https:\/\/doi.org\/10.1007\/s12149-026-02183-3","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"3 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}